Patents by Inventor Richard J. Morse

Richard J. Morse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146591
    Abstract: The present invention relates to a bispecific molecule comprising at least one anti-CD38 domain and at least one anti-PD-L1 domain, which are capable of simultaneous binding to CD38 and PD-L1 antigens, respectively.
    Type: Application
    Filed: November 17, 2022
    Publication date: May 11, 2023
    Inventors: EUGENE ZHUKOVSKY, OLIVIER LEGER, RICHARD J. MORSE
  • Patent number: 11560437
    Abstract: The invention relates to multispecific antibody constructs comprising Fab fragments having a particular set of mutations at the interface of the CH1 and CL domains, the mutations preventing heavy chain/light chain mispairing.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: January 24, 2023
    Assignee: BIOMUNEX PHARMACEUTICALS
    Inventors: Eugene Zhukovsky, Olivier Leger, Richard J. Morse
  • Patent number: 11505616
    Abstract: The present invention relates to a bispecific molecule comprising at least one anti-CD38 domain and at leak one anti-PD-L1 domain, which are capable of simultaneous binding to CD38 and PD-L1 antigens, respectively.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: November 22, 2022
    Assignee: BIOMUNEX PHARMACEUTICALS
    Inventors: Eugene Zhukovsky, Olivier Leger, Richard J. Morse
  • Publication number: 20200299413
    Abstract: The invention relates to multispecific antibody constructs comprising Fab fragments having a particular set of mutations at the interface of the CH1 and CL domains, said mutations preventing heavy chain/light chain mispairing.
    Type: Application
    Filed: March 27, 2018
    Publication date: September 24, 2020
    Inventors: EUGENE ZHUKOVSKY, OLIVIER LEGER, RICHARD J. MORSE
  • Publication number: 20200010559
    Abstract: The present invention relates to a bispecific molecule comprising at least one anti-CD38 domain and at leak one anti-PD-L1 domain, which are capable of simultaneous binding to CD38 and PD-L1 antigens, respectively.
    Type: Application
    Filed: March 27, 2017
    Publication date: January 9, 2020
    Inventors: EUGENE ZHUKOVSKY, OLIVIER LEGER, RICHARD J. MORSE
  • Patent number: 5903923
    Abstract: A baseball cap having distorted graphics applied to the upwardly facing surface of the cap's visor, wherein the graphics are distorted in such a manner as to compensate for perspective and become more easily readable when viewed from a particular viewing position, more particularly, a frontal viewing position. The graphics may be text or pictorial views, and are distorted in such a manner that the distortion compensates for the distortion that normally exists when the visor is viewed from the frontal position whereby the graphics are easier to read or understand when so viewed.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: May 18, 1999
    Assignee: Morse Engineering
    Inventors: Richard J. Morse, Kevin Raming
  • Patent number: RE38394
    Abstract: A baseball cap having distorted graphics applied to the upwardly facing surface of the cap's visor, wherein the graphics are distorted in such a manner as to compensate for perspective and become more easily readable when viewed from a particular viewing position, more particularly, a frontal viewing position. The graphics may be text or pictorial views, and are distorted in such a manner that the distortion compensates for the distortion that normally exists when the visor is viewed from the frontal position whereby the graphics are easier to read or understand when so viewed.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: January 27, 2004
    Assignee: Morse Engineering
    Inventors: Richard J. Morse, Kevin Raming